A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Genes & Development

• Publication date

  1999-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/GAD.13.7.804PMID 10197981PMCID PMC316599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FAST-2 Is a Mammalian Winged-Helix Protein Which Mediates Transforming Growth Factor β Signals

  1999cited by this paper
• Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

  1999cited by this paper
• TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.

  1999cited by this paper
• Advances from genetic clues in pancreatic cancer

  1998cited by this paper
• Smad3 mutant mice develop metastatic colorectal cancer.

  1998cited by this paper
• Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.

  1998influential reference
• TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.

  1998cited by this paper
• Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.

  1998cited by this paper
• Characterization of human FAST-1, a TGFβ and activin signal transducer

  1998cited by this paper
• Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.

  1998cited by this paper
• Signal-specific co-activator domain requirements for Pit-1 activation

  1998cited by this paper
• Functional intertwining of Dpp and EGFR signaling during Drosophila endoderm induction.

  1998cited by this paper
• Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.

  1998cited by this paper
• Characterization of human FAST-1, a TGF beta and activin signal transducer.

  1998cited by this paper
• Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2.

  1998cited by this paper
• Increasing Complexity of the Ras Signaling Pathway*

  1998cited by this paper
• Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling.

  1998influential reference
• TGF-beta signal transduction.

  1998cited by this paper
• Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases.

  1998cited by this paper
• Determinants of specificity in TGF-beta signal transduction.

  1998influential reference
• TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis

  1998cited by this paper
• Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.

  1998cited by this paper
• Regulation of immune responses by TGF-beta.

  1998cited by this paper
• REGULATION OF IMMUNE RESPONSES BY TGF-β*

  1998cited by this paper
• TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity.

  1997cited by this paper
• TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

  1997cited by this paper
• TGFβ in prostate cancer: A growth inhibitor that can enhance tumorigenicity

  1997cited by this paper
• TGF-β signalling from cell membrane to nucleus through SMAD proteins

  1997influential reference
• Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1

  1997influential reference
• A structural basis for mutational inactivation of the tumour suppressor Smad4

  1997cited by this paper
• Cyclin E-induced S phase without activation of the pRb/E2F pathway.

  1997cited by this paper
• Smad4 and FAST-1 in the assembly of activin-responsive factor

  1997cited by this paper
• Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition.

  1997cited by this paper
• The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.

  1997influential reference
• Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition

  1997cited by this paper
• The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2.

  1997cited by this paper
• Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.

  1997cited by this paper
• Transforming growth factor-beta in breast cancer: a working hypothesis.

  1997cited by this paper
• Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression.

  1997cited by this paper
• Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15

  1997cited by this paper
• Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.

  1997cited by this paper
• Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.

  1996cited by this paper
• TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.

  1996cited by this paper
• A transcriptional partner for MAD proteins in TGF-beta signalling.

  1996cited by this paper
• A transcriptional partner for MAD proteins in TGF-β signalling

  1996cited by this paper
• MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

  1996cited by this paper
• The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996influential reference
• Transforming growth factor β1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro

  1996cited by this paper
• A Transcriptional Partner for MAD Proteins in TGF - b Signalling

  1996cited by this paper
• TGFb1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice

  1996cited by this paper
• Transforming Growth Factor β and Cell Cycle Regulation

  1995influential reference
• Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex

  1995cited by this paper
• Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype.

  1995cited by this paper
• PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*)

  1995influential reference
• Transforming growth factor beta and cell cycle regulation.

  1995cited by this paper
• Aberrant function of the Ras signal transduction pathway in human breast cancer

  1995cited by this paper
• Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase.

  1995cited by this paper
• A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines.

  1995cited by this paper
• Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo.

  1995cited by this paper
• Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

  1995influential reference
• p21 Ras as a governor of global gene expression.

  1994cited by this paper
• pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest

  1994cited by this paper
• Mechanism of activation of the TGF-β receptor

  1994influential reference
• Mechanism of activation of the TGF-beta receptor.

  1994cited by this paper
• Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

  1994cited by this paper
• p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

  1994cited by this paper
• Development of resistance mechanisms to the growth‐inhibitory effects of transforming growth factor-β during tumor progression

  1993cited by this paper
• Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

  1993cited by this paper
• The mitogen-activated protein kinase signal transduction pathway.

  1993influential reference
• Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)

  1993cited by this paper
• Release from G1 growth arrest by transforming growth factor beta 1 requires cellular ras activity.

  1993cited by this paper
• Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

  1993cited by this paper
• Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.

  1992cited by this paper
• The regulation of transcription by phosphorylation.

  1992cited by this paper
• Involvement of p21ras in Xenopus mesoderm induction

  1992cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

  1990cited by this paper
• The transforming growth factor-beta family.

  1990influential reference
• Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.

  1989cited by this paper
• Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.

  1989cited by this paper
• Transforming growth factor beta.

  1988cited by this paper
• Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.

  1988cited by this paper
• Cell adhesion protein receptors as targets for transforming growth factor-beta action.

  1987cited by this paper
• Transforming growth factors and control of neoplastic cell growth

  1987cited by this paper
• The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors.

  1986cited by this paper
• Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

  1986cited by this paper
• Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells

  1985cited by this paper

• TGF-beta plays dual roles in immunity and pathogenesis in leishmaniasis.

  2025cites this paper
• The role of cyclic adenosine monophosphate (cAMP) in pathophysiology of fibrosis.

  2025cites this paper
• TGF-β signaling in organoids: The mechanisms and applications in 3D

  2025cites this paper
• TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma

  2025cites this paper
• Computational Modeling and Analysis of the TGF-β-induced ERK and SMAD Pathways

  2024cites this paper
• Alternative Splicing in EMT and TGF-β signaling during Cancer Progression.

  2024cites this paper
• Spatially resolved metabolomics visualizes heterogeneous distribution of metabolites in lung tissue and the anti-pulmonary fibrosis effect of Prismatomeris connate extract

  2024cites this paper
• TGF-β signaling in health, disease and therapeutics

  2024cites this paper
• Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective

  2024cites this paper
• SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell-cycle inhibitors to guide tissue formation

  2024cites this paper
• Targeting the TGF-β signaling pathway: an updated patent review (2021–present)

  2024cites this paper
• Endothelial-to-mesenchymal transition in the tumor microenvironment: Roles of transforming growth factor-β and matrix metalloproteins

  2024cites this paper
• Transcriptional program-based deciphering of the MET exon 14 skipping regulation network

  2024cites this paper
• TGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities

  2024cites this paper
• A platform of functional studies of ESCC-associated gene mutations identifies the roles of TGFBR2 in ESCC progression and metastasis.

  2024cites this paper
• Aldo-keto reductase-7A2 protects against atorvastatin-induced hepatotoxicity via Nrf2 activation.

  2024cites this paper
• EpicTope: narrating protein sequence features to identify non-disruptive epitope tagging sites

  2024cites this paper
• MAPK Phosphatase-5 is required for TGF-β signaling through a JNK-dependent pathway

  2024cites this paper
• Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma

  2024cites this paper
• Structure, unique biological properties, and mechanisms of action of transforming growth factor β.

  2024cites this paper
• Targeted dephosphorylation of SMAD3 as an approach to impede TGF-β signaling

  2024cites this paper
• Differential Smad2/3 linker phosphorylation is a crosstalk mechanism of Rho/ROCK and canonical TGF-β3 signaling in tenogenic differentiation

  2024cites this paper
• Mitogen-Activated Protein Kinase Phosphatase-5 is Required for TGF-β Signaling Through a JNK-Dependent Pathway

  2024cites this paper
• Receptor-activated transcription factors and beyond: multiple modes of Smad2/3-dependent transmission of TGF-β signaling.

  2024cites this paper
• Cell type-specific transforming growth factor-β (TGF-β) signaling in the regulation of salivary gland fibrosis and regeneration

  2024cites this paper
• Cellular Compartmentalization as a Physical Regulatory Mechanism of Signaling Pathways

  2024cites this paper
• Tonic repression of Collagen I by the Bradykinin receptor 2 in skin fibroblasts.

  2023cites this paper
• Jagged1 intracellular domain/SMAD3 complex transcriptionally regulates TWIST1 to drive glioma invasion

  2023cites this paper
• TGF-β mediated drug resistance in solid cancer.

  2023cites this paper
• Shear stress induces autophagy in Schlemm’s canal cells via primary cilia-mediated SMAD2/3 signaling pathway

  2023cites this paper
• Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy.

  2023cites this paper
• Head organizer: Cerberus and IGF cooperate in brain induction in Xenopus embryos.

  2023cites this paper
• Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease.

  2023cites this paper
• Survival and Enrichment Analysis of Epithelial–Mesenchymal Transition Genes in Bladder Urothelial Carcinoma

  2023cites this paper
• State- and stimulus-specific dynamics of SMAD signaling determine fate decisions in individual cells

  2023cites this paper
• A Short-Term Model of Colitis-Associated Colorectal Cancer That Suggests Initial Tumor Development and the Characteristics of Cancer Stem Cells

  2023cites this paper
• Scaffolds containing GAG-mimetic cellulose sulfate promote TGF-β interaction and MSC Chondrogenesis over native GAGs.

  2023cites this paper
• Extracellular matrix stiffness—The central cue for skin fibrosis

  2023cites this paper
• Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone.

  2022cites this paper
• Shifting the Focus of Signaling Abnormalities in Colon Cancer

  2022cites this paper
• Transforming growth factor-β in myocardial disease

  2022cites this paper
• Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.

  2022cites this paper
• An Inhibitory Function of TRPA1 Channels in TGF-β1-driven Fibroblast to Myofibroblast Differentiation

  2022cites this paper
• Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?

  2022cites this paper
• Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?

  2022cites this paper
• TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis

  2022cites this paper
• Functions of exogenous FGF signals in regulation of fibroblast to myofibroblast differentiation and extracellular matrix protein expression

  2022cites this paper
• Extracranial arteriovenous malformations demonstrate dysregulated TGF-β/BMP signaling and increased circulating TGF-β1

  2022cites this paper
• Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules

  2022cites this paper
• SMAD3 mutation in LDS3 causes bone fragility by impairing the TGF-β pathway and enhancing osteoclastogenesis

  2022cites this paper
• Mast Cell Chymase Has a Negative Impact on Human Osteoblasts.

  2022cites this paper
• Evaluation of CRISPR/Cas9 mediated TGIF gene editing to inhibit corneal fibrosis in vitro.

  2022cites this paper
• Epithelial–Mesenchymal Transition by Synergy between Transforming Growth Factor-β and Growth Factors in Cancer Progression

  2022cites this paper
• Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome

  2021cites this paper
• High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition

  2021cites this paper
• Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation

  2021cites this paper
• Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis

  2021cites this paper
• Phosphoinositide-binding activity of Smad2 is essential for its function in TGF-β signaling

  2021cites this paper
• Canonical TGFβ Signaling and Its Contribution to Endometrial Cancer Development and Progression—Underestimated Target of Anticancer Strategies

  2021cites this paper
• Fibrosis of the diabetic heart: clinical significance, molecular mechanisms, and therapeutic opportunities.

  2021cites this paper
• Osteoarthritis-Related Inflammation Blocks TGF-β’s Protective Effect on Chondrocyte Hypertrophy via (de)Phosphorylation of the SMAD2/3 Linker Region

  2021cites this paper
• Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer

  2021cites this paper
• Smad2/3 Activation Regulates Smad1/5/8 Signaling via a Negative Feedback Loop to Inhibit 3T3-L1 Adipogenesis

  2021cites this paper
• RAF-MEK-ERK pathway in cancer evolution and treatment.

  2021cites this paper
• Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53

  2021cites this paper
• Epithelial to Mesenchymal Transition

  2021cites this paper
• A cytokine in turmoil: Transforming growth factor beta in cancer.

  2021cites this paper
• TGFB1/INHBA homodimer/Nodal-SMAD2/3 Signalling Network: A Pivotal Molecular Target in PDAC Treatment.

  2021cites this paper
• TGF‐β signaling: A recap of SMAD‐independent and SMAD‐dependent pathways

  2021cites this paper
• Bone morphogenic protein signaling regulates development and activation of CD4 + T cells

  2021cites this paper
• MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body

  2021cites this paper
• Multiple versus Solitary Giant Cell Lesions of the Jaw: Similar or Distinct Entities?

  2021cites this paper
• TGF-Β Family Inhibitors Blunt Adipogenesis Via Non-Canonical Regulation Of SMAD Pathways

  2020cites this paper
• Bone morphogenetic proteins mediate crosstalk between cancer cells and the tumour microenvironment at primary tumours and metastases (Review).

  2020cites this paper
• Maintenance of the Undifferentiated State in Myogenic Progenitor Cells by TGFβ Signaling is Smad Independent and Requires MEK Activation

  2020influential citation
• Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling

  2020cites this paper
• Transforming growth factor–β in tissue fibrosis

  2020cites this paper
• Adiponectin-Based Peptide (ADP355) Inhibits Transforming Growth Factor-β1-Induced Fibrosis in Keloids

  2020cites this paper
• Smad2 linker region phosphorylation is an autonomous cell signalling pathway: Implications for multiple disease pathologies.

  2020cites this paper
• Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer.

  2020cites this paper
• Long-term model of colitis-associated colorectal cancer suggests tumor spread mechanism and nature of cancer stem cells.

  2020cites this paper
• The Small GTPase RAC1B: A Potent Negative Regulator of-and Useful Tool to Study-TGFβ Signaling

  2020cites this paper
• Differential Role of Smad2 and Smad3 in the Acquisition of an Endovascular Trophoblast-Like Phenotype and Preeclampsia

  2020cites this paper
• SMAD-oncoprotein interplay: Potential determining factors in targeted therapies.

  2020cites this paper
• Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells.

  2020cites this paper
• RIPK3: A New Player in Renal Fibrosis

  2020cites this paper
• Specific Smad2/3 Linker Phosphorylation Indicates Esophageal Non-neoplastic and Neoplastic Stem-Like Cells and Neoplastic Development

  2020cites this paper
• Resistance training‐induced muscle hypertrophy is mediated by TGF‐β1‐Smad signaling pathway in male Wistar rats

  2020cites this paper
• Computational Approaches to Examine Cellular SignallingNetworks

  2020cites this paper
• Polydatin prevents bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/Smad/ERK signaling pathway

  2020cites this paper
• Cdon mutation and fetal alcohol converge on Nodal signaling in a mouse model of holoprosencephaly

  2020cites this paper
• Signal Transduction in Disease

  2019cites this paper
• The function of RAS mutation in cancer and advances in its drug research.

  2019cites this paper
• Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer

  2019cites this paper
• Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer

  2019cites this paper
• Cholesterol deprivation induces TGFβ signaling to promote basal differentiation in pancreatic cancer

  2019cites this paper
• Opposing roles and potential antagonistic mechanism between TGF-β and BMP pathways: Implications for cancer progression

  2019cites this paper
• Analysis of TGFBI Gene Mutations in Three Chinese Families with Corneal Dystrophy

  2019cites this paper
• Dianthus superbus Improves Glomerular Fibrosis and Renal Dysfunction in Diabetic Nephropathy Model

  2019cites this paper
• ERK1/2 drives IL-1β-induced expression of TGF-β1 and BMP-2 in torn tendons

  2019cites this paper